Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH): -- Ignore unavailable to you. Want to Upgrade?

To: michael97123 who wrote (167)	11/11/2003 7:44:50 PM
From: tuck	Respond to of 510

Mike, I'm not expecting any major news for a while. You've presumably read post #165, since it was a reply to one of your posts. My thoughts are there. I think under $10 is relatively safe in the intermediate to long haul. Shorter term, much as I'd like to see some color on the diagnostics front, I'm not holding my breath for news there soon. I think the market as a whole could be wobbly, and that while life sciences capex has picked up, it will likely not boom the way it did a few years ago. I would guess that automation of the front end will in fact drive consumables sales. As such, I don't expect the next few quarters to be any weaker than the previous two, even of instrument sales continue a little weak, so I don't see a lot of downside. But a general market correction could knock off as much as $2 - $3 from the share price. My strategy would to be to accumulate in several chunks under this scenario, piling in pretty hard below $8. Probably a good candidate for sold puts/covered call strategy right now. Cheers, Tuck